Mexico Peritoneal Dialysis Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview
The Mexico Peritoneal Dialysis Market is projected to grow from USD 240.86 million in 2023 to approximately USD 348.40 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.48%.

Market growth is primarily driven by the rising prevalence of chronic kidney disease (CKD) and the increasing adoption of home-based dialysis solutions. As Mexico's population ages and lifestyle-related conditions such as diabetes and hypertension become more widespread, the demand for renal replacement therapies, including peritoneal dialysis, continues to increase. Peritoneal dialysis offers convenience and cost-effectiveness, particularly for patients opting for in-home treatment. Technological advancements in dialysis machines and consumables are improving the procedure’s safety and efficiency, while government healthcare initiatives and supportive reimbursement frameworks are enhancing patient access. A market trend toward personalized, patient-centered care is also accelerating the adoption of home dialysis options, positioning peritoneal dialysis as a key solution in kidney failure management.

Market Drivers

Rising Incidence of Chronic Kidney Disease (CKD)
A major factor contributing to the expansion of the peritoneal dialysis market in Mexico is the growing incidence of chronic kidney disease. Driven by an aging population and increasing rates of diabetes, obesity, and hypertension, CKD is becoming a widespread health concern. In 2021, CKD prevalence in Mexico reached 9,184.9 cases per 100,000 population. This growing patient base is intensifying demand for renal therapies. Peritoneal dialysis presents a practical alternative to hemodialysis, especially for patients requiring home-based care, thereby aligning with the healthcare system's emphasis on decentralization and patient autonomy.

Market Challenges Analysis

High Treatment Costs and Financial Constraints
Despite its clinical benefits, the high cost of peritoneal dialysis remains a significant challenge in the Mexican market. Although more cost-effective than hemodialysis over time, peritoneal dialysis involves notable initial expenses related to equipment, consumables, and patient training. The average annual cost per patient is estimated at approximately USD 15,724. This financial burden can be particularly restrictive for low-income individuals and those lacking adequate insurance coverage. While public health programs aim to improve access, persistent cost-related barriers continue to limit widespread adoption, especially in underserved communities.

Market Segmentation

By Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Automated Peritoneal Dialysis (APD)

By Product:

Peritoneal Dialysis Machines

Peritoneal Dialysis Solutions

Dialysis Catheters

Others

By End-user:

Hospitals

Dialysis Centers

Home Care Settings

By Geography:

Mexico City

Monterrey

Guadalajara

Key Player Analysis

Baxter International Inc.

Fresenius Medical Care

DaVita Inc.

NxStage Medical, Inc.

Medtronic plc

Dialysis Clinic, Inc.

Outset Medical, Inc.

American Renal Associates

Quanta Dialysis Technologies

Biomedica Diagnostics Inc.